Your browser doesn't support javascript.
loading
Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate.
Hartono, Stella P; Sharma, Hemant P; Bundy, Vanessa; Thompkins, Jessica D; Kochis, Suzanne R; Brooks, Joel P.
Afiliação
  • Hartono SP; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, Md.
  • Sharma HP; Division of Allergy and Immunology, Children's National Hospital, Washington, DC; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Bundy V; Division of Allergy and Immunology, Children's National Hospital, Washington, DC; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Thompkins JD; Division of Allergy and Immunology, Children's National Hospital, Washington, DC.
  • Kochis SR; Division of Allergy and Immunology, Children's National Hospital, Washington, DC; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Brooks JP; Division of Allergy and Immunology, Children's National Hospital, Washington, DC; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: joelpbrooks@gmail.com.
J Allergy Clin Immunol Pract ; 10(8): 2172-2175.e1, 2022 08.
Article em En | MEDLINE | ID: mdl-35842413
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hipersensibilidade Limite: Child / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Moldávia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hipersensibilidade Limite: Child / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Moldávia